We have tested the ability of the T cell receptor/3 (TCR-B) transcriptional enhancer (E~) to confer transcriptional activation and tissue-specific V(D)J recombination of TCR-~ V, D, and J segments in a transgenic minilocus recombination substrate. We find that the minimal E~ element, as previously shown for a DNA segment that contained the E/~ element, promotes a high level of substrate D to J~ rearrangement in both B and T cells, but only promotes Va to DJ~ rearrangement in T cells, Thus, both the E~ and E~ elements similarly direct V(D)J recombination of this substrate in vivo, supporting a general role for transcriptional enhancers in the normal regulation of this rearrangement process. Surprisingly, however, we found that both the V~ and DJ~ portion of the constructs were transcribed in an enhancer-dependent fashion (conferred by either E~ or E0) in both B and T lineage cells, including normal precursor B cells propagated in culture. These findings indicate that, at least in some contexts, transcriptional activation, per se, is not sufficient to confer V(D)J recombinational accessibility to a substrate V gene segment.
T
he genes that encode the variable regions of Ig and TCRs are assembled from germline V, D, and J gene segments by a process referred to as V(D)J recombination (1) . Both Ig and TCR variable region gene segments are assembled by a common V(D)J recombination activity during the precursor (pre-) stages of B and T cell differentiation. Within pre-B and pre-T cell populations, the V(D)J recombination process is controlled in several contexts including lineage-specificity (e.g., complete assembly of Ig variable region genes in B cells but not T cells), developmental stage-specificity (e.g., assembly of Ig heavy chain variable region genes before those of Ig light chains), and allelic exclusion (reviewed by [2] [3] [4] [5] ). Since there is a common VDJ recombinase, the regulation of Ig or TCR gene segments that are assembled in particular cells and stages within lymphoid lineages must be effected by modulating the accessibility of substrate gene segments to the recombinase (6) .
V(D)J recombinational accessibility of both Ig and TCR variable region gene segments has been correlated with a number of factors including their transcriptional activity (7) (8) (9) (10) (11) (12) . Direct evidence that transcriptional control elements or closely associated sequences can function in cis to promote V(D)J recombinational accessibility was provided by a transgenic recombination substrate analyses (9) . These studies employed a TCR-B minilocus transgene (VDJ~Cu substrate; see Fig. 1 ) that lacked known transcriptional enhancer elements and that was neither transcribed nor rearranged in lymphoid or non-lymphoid tissues. However, addition of a DNA segment that contained the intronic Ig heavy chain enhancer (E~) element (V~DJ~E~C u substrate; see Fig. 1 ) promoted efficient D to Jo construct rearrangements in most developing lymphocytes.
Various lines of evidence indicate that, for both Ig and TCR loci, V to DJ rearrangements are the most stringently regulated event in the V(D)J recombination process (4, 5, 13, 14) . In this context, the transgenic VDJ~E~C~ minilocus studies also provided evidence for tissue specific elements that control the V~ to DJ~ rearrangement step. Thus, although this transgene underwent D to J~ rearrangements in most developing B and T cells, construct Va to DJ~ rearrangements were almost exclusively limited to T lineage cells (9) . Therefore, additional elements within this construct appear to differentially control accessibility of the construct V~ gene segment in T vs. B cells. Similar specificity of rearrangement also was observed with an independent TCR-~ transgenic recombination substrate (15) .
The exact mechanism by which transcriptional control elements function to confer V(D)J recombinational accessibility remains unclear. In particular, a continuing question has been whether transcription per se of V gene segments is sufficient to generate their recombinational accessibility in developing lymphoid cells. The strict enhancer dependence and clear lineage-specificity with respect to Vt~ to DJo rearrangements of the TCR-fl minilocus recombination substrate provides a model system for in depth studies of the molecular mechanisms of these processes in normal developing lymphocytes. Thus, we have now addressed these issues by assaying for the ability of an unrelated lymphoid-specific enhancer, the minimal TCK-fl enhancer (E~), to promote rearrangement of the V~DJoC~ minilocus and by comparing the transcriptional activity of the V~ and DJ~ portions of the various versions of this substrate in developing B and T lineage cells.
Materials and Methods
Substrate Construction. The recombination substrate VDJEaC~ was assembled from genomic DNA fragments encoding TCR-~3 V~14, Dal.1, Jt~l.1, and 1.2, TCR-/3 enhancer, and the C~ regions as previously described (9, 16) except that the 1.1-kb NaeI-EcoRI IgH enhancer fragment of the VDJaE~C~ construct (9) was replaced with the 560-bp NcoI-HpaI fragment containing the routine TCR-B enhancer (see Fig. 1 ).
Generation and Analysis of Transgenic Mic~
Transgenic mice were generated by injection of the VDJoEaC~ construct into B6/CBA x B6/CBA F1 zygotes as described previously (9) . Integration and copy number of transgenic constructs in the various mice was determined by quantifying the level of the 6-kb Va14-hybridizing BgllI fragment specific for the transgene by Southern blotting analyses of tail or tissue DNA (see Fig. 2 ). The transgenic founder mouse no. 5 harbored two independently segregating integrants of the construct, which were propagated as lines no. 5 (60 copies) and 5.1 (5 copies); founder mouse no. 2 was propagated to establish line 2 (25 copies). Founder no. 6 carried one to two copies of the construct in all analyzed tissues, but did not transmit the gene to >50 offspring analyzed. This mouse was killed at 6 mo of age for analysis. B and T cellpurification. B and T cells were purified from transgenic mice by the "panning" procedure (17) . B cells were isolated as cells adherent to 10-cm polystyrene bacterial petri dishes (Fisher Scientific Co., Pittsburgh, PA) coated with 250 ng/ml polyclonal goat anti-mouse Ig(G+A+M) (Zymed Laboratories, Inc., S. San Francisco, CA); T cells were isolated as nonadherent cells after two rounds of incubation on plates coated with 10 #g/ml goat anti-mouse Ig(G+A+M). B cells were 95 to 98% pure, as determined by FACS | analysis (FACScan| Becton Dickinson & Co., Mountain View, CA) using FITC-conjugated rat anti-mouse B220 and PE-conjugated rat anti-mouse CD5 or a combination of PEconjugated rat anti-mouse CD4 and FITC-conjugated rat anti-mouse CD8 (PharMingen, San Diego, CA) (data not shown). T cells were 80-95% depleted of B cells as determined by FACS | analysis (40-90% CD5 + cells, depending on the non-T, non-B cells in the starting population). Establishment and Analysis of Lymphoid Bone Marrow Culture (LBMC)L Pre-B cell cultures were established from bone marrow of 3-6-wk-old mice as described previously (18, 19) . After 3-4 wk, nonadherent cells were harvested from the cultures for analysis, or 250 U/ml of recombinant human IL-7 was added to the cultures 1Abbreviation used in this paper: LBMC, lymphoid bone marrow culture.
to expand pre-B cells (gift of Stephen GiUis; Immunex Corp., Seattle, WA [20, 21] ). After 1 wk in IL-7-supplemented medium, the nonadherent cells were harvested and contaminating adherent stromal cells were removed by incubating the cells on fresh plates for 24 h. Analyzed cells represented pre-B cells based on expression of characteristic surface markers (BPI*/CD43 +/B220 +/slg-; [22] ) as determined by FACS | analyses after staining with FITC-or PEconjugated, monoclonal rat anti-mouse BP1, CD43, B220, or IgM (PharMingen), as well as by RAG-l, RAG-2, and ~5 expression as determined by Northern blot analyses (23) .
A-MuLV-transformed Cell Lines. A-MuLV transformation of adult bone marrow was performed as described previously (24 5'-TCTAAGCTTAAATCAAGCCCTAACCTCTAC-3'. To detect D-J rearrangements, 5'D0 and 5'C~ (primer set 1DJ) or TCR-/~ (primer set 2DJ) oligos were used. To detect V(DJJ rearrangements, V~14 and 5'C~ (primer set 1VDJ) or TCR-/8 (primer set 2VDJ) oligos were used. PCR-amplified products using 5'Do and 5'C~ or V014 and 5'C~ were analyzed after BamHI digestion, to allow better resolution of the products by gel-electrophoresis. Amplified products were separated on a 1.4% Tris-borate buffered agarose gel, transferred onto zeta-probe membrane (Bio-Rad Laboratories, Inc., Richmond, CA) by alkaline transfer and assayed for hybridization to an oligonucleotide probe to Jo2 (5'-AAAGCCTGG-TCCCTGAGCCGA-3') as previously described (25) . $1 Nuclease Protection Assay. DNA fragments used to generate $1 nuclease protection probes were cloned into pBluescript SK II (Stratagene, La Jolla, CA). 3~p-radiolabeled probes were subsequently generated by in vitro transcription using T3 or T7 polymerase (Stratagene), as previously described (26) . The Va14 $1 probe was previously described (9) . The D-Jo region probe spans the XbaI-EcoRI fragment from the VDJoE~C/z construct. The GAPDH probe was made from amplifying position 945-1261 of GAPDH from murine liver cDNA by PCR and cloning the amplified fragment into pBluescript SKII (Stratagene) (Zhang, J., E. Ohz, and F. Ah, unpublished data and reference 27). Approximately 2-50/zg of total RNA was hybridized to the probes, digested with S1 nuclease and resolved on a denaturing acrylamide gel as previously described (9) . Yeast tRNA (10 #g) was added to reactions that employed lower amount (2/~g) of cellular RNA. Fig. 2 B) . Transgenic founder mouse no. 6 carried a low copy number of the construct in all analyzed tissues (Table 1 and Fig. 2 B) but did not transmit the gene. Therefore, this animal was sacrificed at 6 mo of age for analysis. Lines 5, 5.1, and 2 also harbored incomplete integrations of the transgenes that were evident as V~-specific BgllI fragments of unpredicted sizes (see below) that were unique to each line ( Fig. 2 ; bands denoted with asterisks). The hybridization intensity of these fragments did not change in the various studied tissues (i.e., lymphoid vs. nonlymphoid); therefore they appear to be inactive with respect to recombination and were not further characterized.
Results

Generation of
The E~ Element Promotes V(D)J Recombinational Accessibility.
DNA from various tissues of the VDJaEaC~ transgenic mice was digested with BgllI and analyzed for construct rearrangements by Southern blotting using a probe specific for Vfi14 (Fig. 2 A; reference 9 ). This analysis detects the unrearranged, DJ-rearranged, and VDJ rearranged VDJaE~G, transgenes as V~14-hybridizing BgllI fragments of 5.5, 10.5, and 6.5 kb, respectively; whereas the endogenous Va gene yields a 3.7 kb hybridizing fragment (Fig. 2  A) . We detected construct DJ and V(D)J rearrangements at substantial levels in DNA from thymus of all VDJ~E~C~ transgenic lines and at somewhat lower, but still significant, levels in DNA from lymph nodes and spleen; a low level of construct DJ rearrangements was also detectable in bone marrow of these lines ( Fig. 2 B , Table 1 , and data not shown). No significant rearrangement of the construct was observed in DNA from nonlyrnphoid tissues beyond the very low levels attributable to circulating lymphocytes (Fig. 2 B ; representative data is shown).
The pattern and relative extent of DJ and V(D)J rearrangements of the VDJ~EoCu transgenes was similar to that previously observed for the VDJ~E~C~ transgenic lines (9) (representative data for VDJ~E~C~ Iines 382 and 379 are shown in Fig. 2 , B and C). Significantly, we cannot detect rearrangement of the VDJaC~ construct, which lacks a known enhancer element (Fig. 1 ), in either lymphoid or nonlymphoid tissues of six independent lines of transgenic mice (reference 9; also, see 
T Cell-specific V to DJ Rearrangement of the VDJz?Ez~C~
Transgene. We previously observed D to J rearrangements of the VDJaE~C~ transgene in both B and T lineage cells but found construct VDJ rearrangements only in T cells (9) . To assay for DJ versus VDJ rearrangement of the VDJaE~G, substrate in B versus T cells, we used panning procedures to purify splenic and lymph node B and T cells from the four VDJ~EaC~, lines and the 382 VDJaE~,C~ line; purified B cells were greater than 95% pure as determined by FACS | analysis, while T calls were 80-95% depleted of B ceils (data not shown). DNA isolated from purified B and T cells was assayed for rearrangement of the transgenic substrate by a PCR. assay that employed primer combinations that specifically detect minilocus DJ and VDJ rearrangements (Fig. 3 A) . DNA concentration and the efficiency of the PCtL reaction was controlled by examining the PCR amplification of a separate DNA fragment in the same reaction ( (31, 54) . The /xEBP-E element is also found outside of the core Eu elements as indicated (30, 31) . Note that the inserted elements are drawn on a different scale than the base construct. Table I . "B" denotes B cells; "T" denotes thymus or T cells; "+" indicates detected rearrangement or transcription; "-" indicates lack of rearrangement or transcription; gaps indicate samples not tested; "*" indicates transgenic lines used in this study; ..... indicates transgenic animals described in a prior study (9) . 17-40 denotes the range in the level of rearrangements observed for four independent A-MuLV lines derived from line 5.1. Copy number and percent rearrangement were determined from quantitation of hybridizing signals on Southern blots in Fig. 2 and not shown using Molecular Dynamics phosphorimager and densitometer. Table 1 ).
Summary of Rearrangement and Transc@tional Characterization of Transgenic Mice Harboring Variations of the TCR-~ Recombination Minilocus
line was used as a standard to estimate the relative level of rearrangements in D N A from purified B and T cells of that line whereas liver D N A from the line was used as a "negative" control. We note that even though such P C R assays are only considered "semiquantitative", we obtained results quite consistent with those obtained by the more quantita- Figure 3 . PCR analysis of construct rearrangements. (A). Schematic for primers used to detect substrate rearrangements. Primer set 1DJ (top and middle) and 1VDJ (bottom) and primer set 2DJ (top and middle) and 2VDJ (bottom) were designed to specifically amplify recombination substrate sequences.
Diagrams depict rearrangement toJ~l.1. Arrows depict BamHI sites in the substrate and amplified products. Primer set I was used to detect rearrangements of transgenic recombination substrates VDJaEaC~ (line 382) or VDJ~sC~ (lines 1010 and 1016). Amplified products from PCR of DJ and V(D)J rearrangements using primer set 1 were digested with BamHI before analysis. Primer set 2 was used to detect rearrangements from genomic DNA with transgenic substrate VDJaEt~C~ (mouse 6, lines 2, 5, and 5.1). Amplified products obtained with either set of primers were analyzed by Southern blot for hybridization to an 01igonucleotide probe to Jt~l.2. Predicted BamHI-digested amplified products of D~ to J~1.1 and Jt~l.2 rearrangements using primer set 1DJ (top and middle diagrams) result in hybridizing bands of 450 and 250 bps, respectively; a 1.1-kb BamHl-digested PCR product of an unrearranged substrate also is detected. BamHl digested PCR products of substrate V(D)J rearrangements using primer set 1VDJ result in products of 470 and 330 bps (bottom). PCR using primer set 2DJ of VDJ~EaC~ substrate result in amplified products of 520 and 380 base pairs for DJt~l.1 and DJal.2 rearrangements, respectively, and 1.2 kb for unrearranged substrate (top and middle). Amplification of VDJt~EaC, V(D)J rearrangements using primer set 2VDJ result in products of 470 and 330 bps (bottom). (B) Rearrangement of recombination substrates in purified B and T cells of transgenic mice. 0.5/zg of genomic DNA from transgenic mouse no. 6, and lines 2, 5, 5.1, 382, and 1010 were analyzed by PCR for DJ and VDJ rearrangement of the transgenic recombination substrate as described above. PCR products of DJ and V(D)J rearrangements are shown. PCR to detect DJ and VDJ rearrangements for all samples of each line were performed in parallel, using the same DNA sample in appropriate reactions. The level of relative rearrangement in the samples should be compared to thymus for each line. Thymus DNA for each transgenic line was diluted into liver DNA and amplified in parallel with DNA from B and T cells, since different copy numbers of the recombination substrate affects the sensitivity of the PCR assay for each transgenic line. Amplification of unrearranged substrate using primer set 1DJ and set 2DJ or coamplification of a segment of an unrelated gene for lines 2, 5.1, and 1010 (precursor lymphocyte-specific regulatory light chain [PLR/.C] [551; data not shown) were used to demonstrate equal efficiency within each set of amplification reactions. (C) Rearrangement of recombination substrates in LBMC generated from transgenic mice. PCR were performed on genomic DNA from denoted sources as described in B. Reactions of each set were determined to be equally efficient by amplifying genomic sequence from PLRLC simultaneously (data not shown). (D) Rearrangement of recombination substrates in A-MuLV-transformed pre-B cell lines generated from transgenic mice. PCRs were performed on 0.5/zg of genomic DNA from denoted sources as described in B. PLRLC sequences were amplified simultaneously, showing that samples in each set of reactions were amplified with equal efficiency (data not shown).
of construct DJ rearrangements in D N A from purified peripheral B cells (Fig. 3 B, lane 6 ) and T cells (Fig. 3 B, lane 7) that were usually comparable in m a g n i t u d e to the levels found in the corresponding thymic D N A (Fig. 3 B, lanes   1-3) . However, in all tested lines, V to DJ rearrangement of the VDJt~EaC~ and VDJaE,C~, transgene were found at substantial levels in peripheral T cells (Fig. 3 B, lanes 7 ), but were nearly undetectable in D N A from peripheral B cells (Fig. 3 B, lanes 6) . We observed only a very low level (more than 100x less than that of the corresponding thymus) of D-J and V(D)J rearrangements in liver DNA of mice transgenic for VDJoEaC, and VDJoE~C~ (Fig. 3, B and C, lane 4) that likely result from circulating lymphocytes. Therefore, we conclude that the 560-bp minimal EO element targets rearrangement of this recombination substrate with a tissue-specific profile similar to that observed in the context of the E# element.
To confirm that the lack of construct V(D)J rearrangements observed in peripheral B cells was also a characteristic of pre-B cells, we assayed for construct rearrangements in LBMC pre-B cells and in A We readily detected DJ, but not V(D)J construct rearrangements by Southern blotting analyses of DNA from LBMC and A-MuLV transformed cell lines established from the VDJaEt~C~ and VDJoE,C, transgenic lines (Fig. 2, C lanes   3, 6, 9 , 12, 13, and 14; and Table 1 ). In contrast, neither DJ nor VDJ rearrangements were detected by a similar analysis of DNA from VDJoC~ transgenic A-MuLV transformants (Fig. 2 C, lanes 17-19) . We also assayed for construct DJ and V(D)J rearrangements in DNA from the various LBMC and A-MuLV pre-B cell lines by the more sensitive PCK method to detect potential construct rearrangements that occurred below the detection level of the Southern blotting assay. Thymus and liver DNA samples from the corresponding lines again were used as controls. Even with this sensitive assay, we could not detect rearrangements of the VDJ~C, substrate in DNA from LBMC and A-MuLV transformed cell lines generated from VDJ~C, transgenic mice (Fig. 3 C, line  1010; Fig. 3 D, line 1016) . In contrast, substantial levels of DJ substrate rearrangement, comparable to that of the corresponding thymic DNA, were detected in DNA from all LBMC and A-MuLV-transformed cell lines established from VDJ~EoC~ and VDJ~E~C, transgenic mice (Fig. 3 C) . However, we again could not detect significant levels (levels were at least 100-fold less than that of the corresponding thymus sample) of construct VDJ rearrangements in LBMC and only extremely low levels in some A-MuLV transformants from VDJoE~C~ and VDJ~E~Cu transgenic mice (Fig. 3, C  and D) .
Enhancer Dependent Transcription of the Unrearranged Construct D-J~ Region in B Lineage Cells.
To quantify expres-sion of transcripts from the D-J~ portion of the transgenic recombination substrates, we employed an S1 nuclease protection assay that used a probe which included the D-J~ and Eft regions of the VDJ~EaC~ construct (Fig. 4 A, top) .
A combination of $1 nuclease protection and primer extension analyses of thymic R.NA from VDJ~E~C~ transgenic mice indicated that transcripts initiate from multiple sites in the region of the construct between the D and J~l segment (Ferrier, P., and F. Alt, unpublished data). Thus, hybridization of transcripts that span the entire region of the probe will result in a 950-bp protected fragment in RNA from VDJ~E~C~ transgenic lines and a 490-bp fragment in KNA derived from VDJflE~C~ or VDJ~C~ lines, whereas transcripts that initiate internal to the probe protect a series of smaller fragments. Potential transcripts from VDJ~EflC~ DJ~I or DJ~2 rearrangements would protect probe fragments of 870 or 740 bp whereas those from VDJ~E~C~ or VDJ~C~ rearrangements would protect fragments of 310 or 180 bp. As a control, we also quantitated expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts simultaneously or in parallel (Fig. 4 B) .
We did not detect transcripts of the unrearranged construct D-J region in KNA from thymus, liver, LBMC, or A-MuLV transformants derived from VDJ~C~ transgenic animals (reference 9 and Fig. 4 B, top; lanes 5-9) . In contrast, we detected D-J region construct transcripts in KNA from thymus, LBMC and A-MuLV transformants, but not liver, from both VDJ~E~C~ and VDJflE~C~ transgenic mice (Fig. 4 B, top;  lanes 2-4, 10-15, and 18-24) . Thus, DNA fragments containing either the E~ or E~ enhancers activate transcription through the De and J~ portion of the transgenic minilocus in both pre-B cells and thymocytes.
Enhancer-dependent Transcription of Unrearranged Substrate V# Segments in B Lineage
Cells. We employed a probe spanning the 3' end of the construct V~14 segment (Fig. 4 B, bottom) in $1 nuclease protection assays to detect transcripts derived from this portion of the transgenic constructs; this probe detects transcripts from unrearranged and rearranged V~14 segments as protected fragments of 340 and 90 bp (Fig. 4 A, bottom) . Because this probe does not distinguish between construct-derived and endogenous Va-containing transcripts; transgene expression is detected by quantitative comparison of transcript levels in corresponding RNA samples from transgenic and nontransgenic sources (9) .
We detected transcripts of germline and rearranged V014 segments at levels well above nontransgenic background in RNA from thymus, but not liver, of all mice transgenic for VDJt3E~C~ or VDJaE~C~ constructs (Fig. 4 B, bottom, lanes  2-4, 10-15, and 18-24) . In contrast, we did not detect levels of V~14 transcripts in thymus R.NA of VDJ~C~ transgenic mice above those of nontransgenic mice (reference 9, Fig.   4 B, bottom, lanes 5-9 and data not shown) . Thus, the E~ enhancer, like the Eu enhancer (9), can activate transcription of the unrearranged construct Va segment in thymocytes. Surprisingly, purified peripheral B cells from VDJoEuC~ or VDJ~E~C~ mice expressed levels of Vf114 transcripts that were reproducibly as high or higher than those found in RNA from the corresponding thymuses (Fig. 4 C) . To determine regions of the recombination substrate in tissues and cell lines generated from transgenic mice. 10/xg of total RNA from indicated sources were simultaneously assayed for hybridization to the substrate DJ region (top) and GAPDH (middle) probes; hybridization to the V~14 probe (bottom) was assayed in with duplicate RNA samples. Bands corresponding to unrearranged and rearranged D-J transcripts and unrearranged Va14 segments are indicated. Bands corresponding to undigested probe in V~14 protection assays are denoted. (C) Transcripts of the Va14 region of the recombination substrate in long-term LBMC and purified B cells from transgenic mice. Approximately 2/xg of total RNA was assayed from thymus, liver, non-adherent cells from long-term LBMC and purified B cells were assayed for transcription of the unrearranged V~14 segment. Transcription of GAPDH was assayed simultaneously.
whether the V~ portion of these transgenes was also expressed in pre-B cells, we assayed RNA from LBMC. Again, we reproducibly detected unrearranged V~14 gene transcripts in LBMC (cultured with or without added IL-7) established from all tested VDJ~E,C~ or VDJ~EaC, lines at levels that often approached those of the corresponding thymic RNA; these transcripts were enhancer dependent as none were detected in LBMC established from VDJoC, transgenic mice (with IL-7, Fig. 4 B bottom, lanes 6, 12, 20 , and 24; without IL-7, Pig. 4 C, lane 3). Because the V~ expression levels in cultured pre-B, peripheral B, and thymic T cells from a given transgenic line were roughly proportional to VDJaE, C, and VDJaEaC~ copy numbers (which range from a few to about 100), it also would appear that most copies of the transgene are expressed in each of these cell types (see Fig. 4 , B and C). As with VDJ~E~Cg mice (9), we could not readily detect V~3 transcripts in total bone marrow of the VDJ~EoC, mice (data not shown). Assuming that normal pre-B cells express this transcript at the same level as those in LBMC, the difficulty in detecting these transcripts in total bone marrow is consistent with the low level of B lineage cells in this tissue (28) .
Analyses of V~14 expression in A-MuLV transformants derived from the various transgenic lines yielded results that were generally in accord with those obtained from normal B lineage cells. Thus, we also detected unrearranged V~14 transcripts in VDJ~EuCu and VDJaE~C~ A-MuLV transformants (see Fig. 4 B) . However, the expression level of these transcripts often was lower than that of the corresponding LBMC culture (see Fig. 4 B) , possibly due to downregulation of transgene expression in these transformed lines. Downregulation of the expression of some endogenous lymphoidspecific genes has been clearly documented in such lines (29) . We did not detect unrearranged V~14 transcripts in RNA from nontransgenic A-MuLV transformants (see Fig. 4 B,   lanes 16 and 17) . We also did not detect these transcripts in 2 of 3 tested A-MuLV transformants from the VDJ~C~ transgenic line; in the other line they occurred at extremely low levels (see Fig. 4 B, lanes 7-9) .
We did not detect protected fragments that clearly cor-responded to transcripts of rearranged Vfl segments in RNA from LBMC or peripheral B cells. However, we occasionally observed protected fragments that migrated roughly at this size (80 bp) in some LBMC sample (data not shown). The latter fragments were likely artifactual due to probe or RNA degradation because they usually were not found in repeat experiments with samples from the same source and because there were no detectable Vfl rearrangements in the DNA from these sources. On the other hand, we did detect very low but reproducible levels of protected fragments that corresponded to rearranged Va transcripts in RNA from A-MuLV transformants derived from VDJflE~C~ mice; these probably derived from the low level of construct V~ rearrangements found in these cell lines (Fig. 3 C) .
]~scuss~on
The Minimal TCR-fl Enhancer Activates D to J TCR-fl Minilocus Rearrangements in B and T Lineage Cells.
We have demonstrated that addition of the minimal TCR-fl enhancer region to the VDJ~C~, construct activates its transcription and rearrangement in developing B and T lineage cells in a fashion essentially identical to that which we previously observed for a larger DNA fragment that contains the E/z dement. The "core" E~, and Ea dements are unrelated; although the E~,-containing sequence employed in our earlier studies contained one site, gEBP-E (30-32) also found in the core E~ dement.
The ability of both the E. and E~ enhancer elements to direct rearrangement of the TCP.-fl minilocus in a c/s-dominant fashion suggests that these and other Ig or TCP.. transcriptional enhancers may function as "recombination" enhancers in their endogenous setting. Accordingly, recent gene-targeted mutation studies demonstrated that deletion or replacement of the endogenous E~ dement significantly reduced the rearrangement level of the associated Jr~ segments (33, 34) . However, the E~ deletion did not eliminate Jr~ rearrangements. Therefore, it is likely that the VDJflC. construct lacks additional dements present in the endogenous IgH locus that promote rearrangement independently from the E. dement but that may act synergistically with E. to confer full V(D)J recombinational accessibility. Thus, the VDJ~C. minilocus should provide a system to identify and further characterize such dements.
Enhancer-dependent Transcriptional Activation of the Minilocus Recombination Substrate. The unrearranged V~14 segment and the D-J~ portion of the VDJ~E~Cg and VDJ~EaC. but not VDJ~C~ transgenes are transcribed in both T and B lineage ceils. Thus, the generation of both types of transcripts is enhancer-dependent. Correspondingly, the E~ and E~ elements can activate multiple promoters over long distances in B and T lineage cells (31, (35) (36) (37) (38) (39) . Notably, the endogenous TCR D-J~ locus and V~14 gene segment generally are transcribed in T but not B lineage cells. Therefore, transcription of these regions of the TCK-fl locus are differentially regulated in the minilocus vs. the endogenous locus, even in the context of the E~ element. As the V~14 segment is further from the Ea element in the transgene than in the en-dogenous locus, it is unlikely that distance effects with respect to these sequences are responsible for transcriptional activation in B cells. Thus, as previously proposed (31, 36) , endogenous elements in addition to the core E~ element likely contribute to T cdl-specific transcription of V~ and D-J0 sequences.
Potential Relationships between Transc@tional Activation and V(D)J Recombinational Accessibility. Transcription has been
shown to promote homologous recombination (40) (41) (42) . Likewise, V(D)J recombinational accessibility of endogenous and stably transfected variable region gene segments has been correlated both with transcription (6, 7, 12, 43, 44) and with the cis-acting functions of transcriptional enhancer elements (9, 25, 45 ; this study). However, with respect to V(D)J recombination, the nature of the relationship between these processes has remained unclear. The recombinational enhancement of DJ~ rearrangements conferred by the two different enhancer elements in our substrates again correlates well with their transcriptional enhancement of the same region of the substrate. However, our data suggest a surprising dichotomy between V~14 transcription and rearrangement in B lineage cells.
We detected essentially no rearrangements of the V~14 segments of VDJ~E~C~, or VDJ~E~,Co transgenes in any normal B lineage cells. Yet, we dearly detected transcription of the unrearranged substrate V~14 segment in both early and late-stage B lineage cells. These results indicate that enhancer dependent transcription of the minilocus Vf114 segment occurs throughout all stages of early B cell development, including stages that undergo V(D)J recombination of endogenous Ig loci. Several lines of evidence indicate that the transcripts that we have detected originate from the complete transgene substrate, rather than an aberrantly integrated copy. Thus, the transcripts are lymphocyte-specific (indicating enhancer dependence) and correspond in steady-state level in the various lines in rough proportion to the transgene copy number of the line. Thus, our current studies make the unexpected and novel observation that a transcribed variable region gene segment still may not be accessible to V(D)J recombinase, indicating that, at least in some contexts, transcription per se of a variable region gene segment is not sufficient to promote its recombinational accessibility. A similar situation apparently exists with respect to control of Ig heavy chain class switch recombination; gene targeted mutations that generate constitutive transcription through the Ig C~ switch recombination sequences do not promote significant levels of switching to that region in appropriately activated B ceils (46) .
The potential relationship between transcriptional activation and recombinational accessibility has also been the subject of studies that have taken the converse approach of assaying for rearrangement of apparently nontranscribed substrates. Transiently transfected recombination substrates were shown to recombine in the absence of transcriptional control dements and steady-state transcripts (47) . However, such observations may not be directly relevant to normal control mechanisms, as genes on small extra chromosomal substrates are likely subject to different regulatory constraints than chromosomally integrated genes. In another study, transgenic V~ and J~ segments were found to rearrange in the absence of detectable steady-state transcripts from the recombination substrates (48) ; but levels of detected rearrangements were very low, the absence of transcription was not directly demonstrated, and assays were done only in mature B lineage cells. Therefore, there still is no compelling evidence that a chromosomal locus can undergo effcient V(D)J recombination in the absence of transcriptional activation and/or transcriptional control elements.
Several studies have shown that accessibility is strongly correlated with hypomethylation of substrate loci (49) (50) (51) . Due to the lack of informative restriction endonuclease sites, we could not directly address this issue with respect to the Va gene segment portion of our constructs. However, as transcribed genes are usually hypomethylated (52), we would expect this to be the case for the Va and DJt~ regions of our construct in both B and T lineage cells. Even so, recent targeted mutational analyses of the Eu element and flanking sequences indicated that hypomethlyation also may not be sufficient to render the endogenous JH locus fully accessible for V(D)J recombination (34) .
In summary, it appears that, at least in some contexts, neither transcriptional activation nor hypomethylation of chromosomal variable region gene segments is sufficient to render them fully accessible for V(D)J recombination. Conversely, efficient rearrangement of nontranscribed or methylated chromosomal variable region gene segments has not been clearly documented. Thus, it remains possible, and even likely, that transcription and/or transcriptional enhancing element plus demethylation may be necessary companions of full V(D)J recombinational accessibility; but that additional factors further modulate the control of this process in some contexts.
Differential Control of D to J and V to DJ Rearrangements. Various lines of evidence indicate that, for both Ig and TCR loci, V to DJ rearrangement is the most strictly regulated V(D)J recombination event, both in the context of tissue specificity and allelic exclusion (12) (13) (14) 53) . Unlike many other test systems, this aspect of normal control is dearly reproduced in our transgenic recombination substrates, possibly due to the composition of the construct and/or its relatively large size (which may obviate position effects). In this regard, our current findings are consistent with a model in which D and J recombination events are promoted by E~ functions identical to or closely associated with its transcriptional enhancing activities whereas the more stringently regulated V to DJjoining event may be influenced by additional positive or negative control elements that ensure appropriate specificity.
